SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Isolyser (OREX)- Any comments
OREX 0.223-34.4%Apr 3 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: W. Kent Ward who wrote (265)2/10/1997 11:58:00 AM
From: Eric Hovdesven   of 617
 
All, not much to add, out of town when quarter results came out. Taylor should have at least indicated if OREX sales have improved or not, I am concerned that he did not. Everything I read by users states that OREX is a good product. But if OREX sales have not improved then I wonder what is the truth. Come to think of it, the head of Microtek very quickly after the merger, especially since he was touted as being a valuable addition to the company. I agree with the earlier comment that the activity after $8 may indicate a real disparity in information availablity (ie. some knew of the results before hand).

I really should sell my Isolyser but I am still hoping that the OREX sales figure will show some signs of improvement and that the product is good. Although if Taylor is always wrong about financial results is he also wrong about the potential of OREX as a product?

Also it appears there is an operating loss AND then a loss from the reserves. The reserves do not bother me as much as the failure by ISOLYSER management to call this quarter.

Thanks
Eric
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext